The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies

Conference contribution


Publication Details

Author(s): Lehmann C, Heger L, Neubert K, Harzer C, Amon L, Yamazaki S, Heidkamp G, Eissing N, Krug A, Leusen J, Ravetch J, Nimmerjahn F, Dudziak D
Publication year: 2017
Volume: 15
Pages range: 83-84
ISSN: 1610-0387
eISSN: 1610-0379


FAU Authors / FAU Editors

Amon, Lukas
Hautklinik
Dudziak, Diana Prof. Dr.
Professur für die Biologie Dendritischer Zellen
Harzer, Christina
Professur für Immunologie
Heger, Lukas Dr.
Hautklinik
Heidkamp, Gordon Frederik
Hautklinik
Lehmann, Christian Dr. rer. nat.
Hautklinik
Nimmerjahn, Falk Prof. Dr.
Lehrstuhl für Genetik


External institutions with authors

Hokkaido University (Hokudai) / 北海道大学
Ludwig-Maximilians-Universität (LMU)
Rockefeller University
University Medical Centre Utrecht (UMC Utrecht)


How to cite

APA:
Lehmann, C., Heger, L., Neubert, K., Harzer, C., Amon, L., Yamazaki, S.,... Dudziak, D. (2017). The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies. (pp. 83-84).

MLA:
Lehmann, Christian, et al. "The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies." 2017. 83-84.

BibTeX: 

Last updated on 2018-23-11 at 10:08